Clinical trial
An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With…
NCT00302367 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00302367 |
|---|---|
| Title | An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects |
| Official title | An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | OROS methylphenidate hydrochloride, immediate release methylphenidate hydrochloride |
| Enrollment | 20 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Mar 14, 2006 |
| Last update posted | Jul 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: